Development of cytarabine prodrugs and delivery systems for leukemia treatment

Author： Chhikara Bhupender S   Parang Keykavous  

Publisher： Informa Healthcare

ISSN： 1742-5247

Source： Expert Opinion on Drug Delivery, Vol.7, Iss.12, 2010-12, pp. : 1399-1414

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug delivery systems for the treatment of rheumatoid arthritis

By Tarner Ingo H   Müller-Ladner Ulf  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 9, 2008-09 ,pp. : 1027-1037

Informa Healthcare

Access to resources Recommend Favorite

Drug delivery systems in the treatment of African trypanosomiasis infections

By Kroubi Maya   Karembe Hamadi   Betbeder Didier  

Expert Opinion on Drug Delivery, Vol. 8, Iss. 6, 2011-06 ,pp. : 735-747

Informa Healthcare

Access to resources Recommend Favorite

New non-oral drug delivery systems for Parkinson's disease treatment

By Md Shadab   Haque Shadabul   Sahni Jasjeet Kaur   Baboota Sanjula   Ali Javed  

Expert Opinion on Drug Delivery, Vol. 8, Iss. 3, 2011-03 ,pp. : 359-374

Informa Healthcare

Access to resources Recommend Favorite

Novel vesicular and particulate drug delivery systems for topical treatment of acne

By Castro Gisele A   Ferreira Lucas AM  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 6, 2008-06 ,pp. : 665-679

Informa Healthcare

Access to resources Recommend Favorite

Drug delivery systems for the topical treatment of cutaneous leishmaniasis

By Carneiro Guilherme   Aguiar Marta Gontijo   Fernandes Ana Paula   Ferreira Lucas Antônio Miranda  

Expert Opinion on Drug Delivery, Vol. 9, Iss. 9, 2012-09 ,pp. : 1083-1097

Informa Healthcare

Access to resources Recommend Favorite